EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Scientific Evidence on the Involvement of the Proteins ICAM1, PCSK9, NGAL, and MMP9 in the Progression of Endothelial Dysfunction. A Systematic Review and Epistemic Meta-Analysis

Moreno Trujillo U, Altamirano Bustamante M, Manuel Apolinar L, Revilla Monsalve C, De La Chesnaye E

Journal of Clinical and Medical Reviews · 2025

DOI: 10.58489/2836-2330/025 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Clinical and Medical Reviews, 2025. Verfasst von Moreno Trujillo U und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Cardiovascular diseases (CVD) constitute the leading cause of death worldwide. It is documented that obesity, dyslipidemia, diabetes mellitus, and hypertension, all of which are components of the metabolic syndrome, constitute high-risk factors for the development of CVD. Because the prevalence of these components is sufficiently high, various studies have focused on identifying biomarkers associated with the occurrence of these metabolic alterations and endothelial dysfunction. Given their roles in endothelial activation, lipid regulation, and extracellular matrix degradation - fundamental processes in the progression of acute coronary syndrome (ACS) - we focus on four key proteins: ICAM-1, PCSK9, NGAL (also known as lipocalin-2), and MMP-9. Therefore, this study aims to identify scientific evidence studying the role of these biomarkers in endothelial pathophysiology and the variations in their serum concentrations in patients with metabolic syndrome undergoing percutaneous coronary intervention (PCI).

Methods

To achieve this, we conducted a systematic literature search in PubMed, Web of Science, and BIREME databases, following the PICO strategy and PRISMA guidelines.

Results

A total of 53 articles with a methodological quality score ≥60% were included. We organized the evidence into thematic axes to integrate heterogeneous findings and assess the scientific coherence of the mechanisms underlying endothelial dysfunction. From this analysis, our results showed that ICAM-1 correlates with endothelial activation driven by a proinflammatory state and with the occurrence of major adverse cardiovascular events (MACE); PCSK9 is associated with elevated LDL serum concentrations and endothelial cell apoptosis, whereas NGAL and MMP-9 act synergistically in extracellular matrix degradation and atherosclerotic plaque instability. Notably, no studies have simultaneously evaluated all four proteins in patients with metabolic syndrome undergoing PCI, revealing a gap in clinical and molecular knowledge.

Conclusions

Therefore, taken together, these biomarkers emerge as early predictors of cardiovascular risk and represent potential tools for preventive and personalized vascular risk stratification in patients with metabolic syndrome.

Zitieren

APA

U, M. T., M, A. B., L, M. A., C, R. M., & E, D. L. C. (2025). Scientific Evidence on the Involvement of the Proteins ICAM1, PCSK9, NGAL, and MMP9 in the Progression of Endothelial Dysfunction. A Systematic Review and Epistemic Meta-Analysis. Journal of Clinical and Medical Reviews. https://doi.org/10.58489/2836-2330/025

Vancouver

U MT, M AB, L MA, C RM, E DLC. Scientific Evidence on the Involvement of the Proteins ICAM1, PCSK9, NGAL, and MMP9 in the Progression of Endothelial Dysfunction. A Systematic Review and Epistemic Meta-Analysis. Journal of Clinical and Medical Reviews. 2025. doi:10.58489/2836-2330/025

BibTeX
@article{U2025,
  author = {U, Moreno Trujillo and M, Altamirano Bustamante and L, Manuel Apolinar and C, Revilla Monsalve and E, De La Chesnaye},
  title = {Scientific Evidence on the Involvement of the Proteins ICAM1, PCSK9, NGAL, and MMP9 in the Progression of Endothelial Dysfunction. A Systematic Review and Epistemic Meta-Analysis},
  journal = {Journal of Clinical and Medical Reviews},
  year = {2025},
  doi = {10.58489/2836-2330/025}
}
Kostenlos starten →